Skip to main content

Table 2 Change between baseline and follow-up in the frequency per week of reasons for consultationa

From: The effect of COVID-19 pandemic and lockdown on consultation numbers, consultation reasons and performed services in primary care: results of a longitudinal observational study

 

Baseline

Follow-Up

Change

p

padj b

Adverse drug reaction

8.5 ± 22.0

4.2 ± 4.7

-50.5%

0.054

0.157

Total gastrointestinal tract

17.6 ± 19.7

10.0 ± 13.4

-43.0%

0.001

0.041

Lipid metabolism disorder

22.0 ± 37.3

13.7 ± 24.1

-37.6%

0.059

0.156

Lower gastrointestinal tract

11.7 ± 15.2

7.4 ± 14.6

-36.9%

0.038

0.157

Weight/dietary problems

19.5 ± 45.6

12.3 ± 35.3

-36.8%

0.205

0.397

Upper gastrointestinal tract

16.1 ± 16.1

10.2 ± 11.5

-36.5%

0.003

0.041

Vertigo

11.5 ± 12.2

7.4 ± 7.3

-35.7%

0.004

0.027

Spinal disorders

34.8 ± 29.1

22.8 ± 28.4

-34.6%

0.003

0.028

High blood pressure

40.0 ± 45.8

26.9 ± 44.1

-32.8%

0.037

0.176

Somatoform disorders

22.3 ± 26.2

15.3 ± 23.7

-31.6%

0.043

0.156

General fatigue and weakness

20.0 ± 19.4

13.7 ± 14.1

-31.5%

0.008

0.047

Lymph/leg oedema, chronic wounds

6.9 ± 9.2

5.0 ± 7.2

-28.1%

0.090

0.218

Coronary heart disease

16.4 ± 21.5

12.0 ± 35.2

-26.7%

0.279

0.477

Congestive heart failure

12.1 ± 16.9

8.9 ± 16.7

-26.3%

0.175

0.390

Cardiac arrhythmia

12.0 ± 18.5

9.3 ± 10.0

-22.3%

0.194

0.402

Dementia

8.4 ± 15.3

6.8 ± 11.8

-19.2%

0.393

0.569

Diabetes mellitus (all types)

21.9 ± 26.3

17.7 ± 27.6

-19.2%

0.263

0.477

Thyroid disorder

10.2 ± 17.3

9.5 ± 23.4

-6.0%

0.832

0.862

Arthrosis of the large joints

9.6 ± 9.2

9.7 ± 14.1

1.9%

0.914

0.914

Shoulder pain

6.6 ± 6.7

6.9 ± 9.0

5.2%

0.756

0.812

Acute infections of the respiratory tract

40.2 ± 39.1

42.6 ± 45.9

5.9%

0.686

0.795

Mild mental disorders

15.3 ± 18.5

16.5 ± 28.2

7.5%

0.730

0.814

Headache

9.2 ± 9.3

10.3 ± 13.6

11.9%

0.497

0.626

Urinary tract infection

5.8 ± 4.4

6.7 ± 7.6

15.4%

0.296

0.476

Chronic obstructive pulmonary disease

7.3 ± 9.1

8.7 ± 15.3

19.5%

0.420

0.580

Family, partnership problems

9.1 ± 16.2

11.2 ± 22.2

24.0%

0.421

0.555

Chronic kidney disease

5.7 ± 15.4

7.1 ± 21.2

24.5%

0.588

0.711

Asthma

6.3 ± 9.9

8.1 ± 15.0

27.4%

0.326

0.497

Workplace issues, unemployment

7.0 ± 9.3

13.3 ± 30.3

90.2%

0.045

0.144

  1. a sorted in ascending order by change between baseline and follow-up; b α-level Benjamini-Hochberg-adjusted for 29 statistical tests; statistically significant results in bold and italic